Anagrelide is an anti-megakaryocytic and not an anti-platelet agent

Lignende værker

• Rho GTPases and their downstream effectors in megakaryocyte biology
  af: Irina Pleines, et al.
  Udgivet: (2019-01-01)
• The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes
  af: Lore De Kock, et al.
  Udgivet: (2020-11-01)
• Platelets and megakaryocytes: protocols and perspectives volume 4
  af: Amandeep Kaur, et al.
  Udgivet: (2019-04-01)
• Platelet <i>Versus</i> Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
  af: Cédric Garcia, et al.
  Udgivet: (2022-04-01)
• Anagrelide is an anti-megakaryocytic and not an anti-platelet agent
  af: Steve P. Watson, et al.
  Udgivet: (2019-01-01)